总时间（秒）：12.34
问答时间（秒）：10.80

{
        "Variants Include": [
            {
                "Gene": "ALS2",
                "variants": [
                    {
                        "HGVS": "NM_014678.5:c.213C>T",
                        "cDNA Change": {
                            "transcript": "NM_014678.5",
                            "ref": "C",
                            "alt": "T",
                            "position": "213"
                        },
                        "Protein Change": {
                            "ref": "Q72P",
                            "alt": "Q70P"
                        },
                        "Description in input context": "The variant causes a substitution of amino acid glutamine (Q) at position 72 with proline (P), resulting in a change from Q72 to Q70."
                    }
                ]
            }
        ],
        "Described Disease": {
            "Described Disease": "Amyotrophic Lateral Sclerosis (ALS)",
            "MONDO": "MONDO:0004235"
        },
        "Experiment Method": [
            {
                "Assay Method": "Sanger Sequencing",
                "Material used": {
                    "Material Source": "Blood samples from ALS patients and controls",
                    "Material Name": "NA",
                    "Description": "Blood samples were collected from ALS patients and controls for DNA sequencing."
                },
                "Readout type": "Qualitative",
                "Readout description": [
                    {
                        "Variant": "NM_014678.5:c.213C>T",
                        "Conclusion": "Pathogenic",
                        "Molecular Effect": "complete loss-of-function",
                        "Result Description": "The variant NM_014678.5:c.213C>T was present in ALS patients, but not in controls."
                    }
                ],
                "Biological replicates": {
                    "Biological replicates": "NA",
                    "Description": "Since this is a diagnostic test, biological replicates are typically not necessary for Sanger Sequencing."
                },
                "Technical replicates": {
                    "Technical replicates": "2",
                    "Description": "Each sample was sequenced twice to ensure the accuracy of the results."
                },
                "Basic positive control": {
                    "Basic positive control": "NA",
                    "Description": "Since this is a diagnostic test, a basic positive control is not typically included for Sanger Sequencing."
                },
                "Basic negative control": {
                    "Basic negative control": "NA",
                    "Description": "Since this is a diagnostic test, a basic negative control is not typically included for Sanger Sequencing."
                },
                "Validation controls P/LP": {
                    "Validation controls P/LP": "NA",
                    "Counts": "0"
                },
                "Validation controls B/LB": {
                    "Validation controls B/LB": "NA",
                    "Counts": "0"
                },
                "Statistical analysis method": {
                    "Statistical analysis method": "NA",
                    "Description": "Since this is a diagnostic test, statistical analysis is not typically required for Sanger Sequencing."
                },
                "Threshold for normal readout": {
                    "Threshold for normal readout": "Absence of the variant in ALS controls.",
                    "Source": "Custom"
                },
                "Threshold for abnormal readout": {
                    "Threshold for abnormal readout": "Presence of the variant in ALS patients.",
                    "Source": "Custom"
                },
                "Approved assay": {
                    "Approved assay": "Yes"
                }
            }
        ]
    }